The CORALreef Lipids trial in patients with elevated cholesterol (hypercholesterolaemia) at risk of atherosclerotic ...

MSD has agreed to acquire UK biopharma company Verona Pharma in a $10bn deal, strengthening its cardio-pulmonary care ...

Astex Pharmaceuticals, and MSD (Merck), have revealed a worldwide research collaboration, intending to identify small molecule candidates with activity towards a tumor suppressor protein for the ...

The biopharmaceutical company lycera has announced a collaboration agreement with Merck, Sharpe & Dohme (MSD) that will focus on developing and commercializing small-molecule therapies for treating a ...

COPENHAGEN - Evaxion Biotech A/S (NASDAQ: EVAX), a clinical-stage TechBio company, has entered into an option and license agreement with pharmaceutical giant MSD, known as Merck & Co., Inc. in the U.S ...

The company will expand its production facilities in Carlow and Cork to meet increased global demand for its medicines and vaccines produced in Ireland. MSD, known as Merck in the US and Canada, ...